双相障碍多基因风险评分在青少年家族传递中的作用
该社区病例对照纵向研究(匹兹堡生物学子代研究)纳入双相障碍I/II型父母及其子代与无双相障碍父母及其子代,发现双相障碍多基因风险评分在患病父母和子代中均较高,且父母双相障碍诊断与子代多基因风险评分独立关联子代双相障碍风险,但多基因风险评分关联较小,尚不能单独用于确定双相障碍风险。
要点
- 双相障碍父母子代的双相障碍(23.1% vs 5.1%)和抑郁(50.2% vs 32.9%)发生率均高于无双相障碍父母子代。
- 双相障碍多基因风险评分在患病父母(OR 1.50)和患病子代(HR 1.34)中均较高,分别解释4.8%和5.0%的表型方差。
- 父母双相障碍诊断与子代双相障碍风险的关联(HR 5.21)强于父母或子代多基因风险评分,解释30%的方差。
核心结论
- 父母双相障碍与子代双相障碍多基因风险评分独立关联子代双相障碍风险,但多基因风险评分关联较小,尚不能单独用于确定双相障碍风险,需进一步研究。
研究设计与样本
- 社区病例对照纵向研究(匹兹堡生物学子代研究),纳入双相障碍I/II型父母及其子代与无双相障碍父母及其子代,2001年3月至2007年5月招募,2020年12月至2021年9月分析。
主要发现
- 双相障碍父母子代的双相障碍发生率高于无双相障碍父母子代(58例[23.1%] vs 8例[5.1%];P < .001)。
- 双相障碍父母子代的抑郁发生率高于无双相障碍父母子代(126例[50.2%] vs 52例[32.9%];P < .001)。
- 双相障碍多基因风险评分在患病父母中较高(OR 1.50;95%CI 1.19-1.89;P < .001;解释4.8%表型方差),在患病子代中较高(HR 1.34;95%CI 1.03-1.7;P = .02;解释5.0%表型方差)。
- 双相障碍多基因风险评分在双相障碍亚型间无差异。
- 在联合父母与子代双相障碍多基因风险评分的模型中,父母双相障碍多基因风险评分与子代双相障碍的关联完全由子代双相障碍多基因风险评分中介(HR 1.40;95%CI 1.05-1.86;P = .02)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 双相障碍多基因风险评分的关联相对较小,尚不能单独用于确定双相障碍风险,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Establishing genetic contributions to the transmission of bipolar disorder (BD) from parents to offspring may inform the risk of developing this disorder and further serve to validate BD in youth. OBJECTIVE: To evaluate the specific association of BD polygenic risk scores (PRSs) on the familial transmission and validity of pediatric BD. DESIGN, SETTING, AND PARTICIPANTS: This community-based case-control longitudinal study (Pittsburgh Biological Offspring Study) included parents with BD I/II and their offspring and parents without BD (healthy or non-BD psychopathology) and their offspring. Participants were recruited between March 2001 and May 2007, and analysis took place from December 2020 to September 2021. EXPOSURES: PRSs for BD, major depressive disorder, schizophrenia, and attention-deficit/hyperactivity disorder. MAIN OUTCOMES AND MEASURES: Participants were prospectively evaluated using standardized interviews blind to parental diagnosis. DNA was extracted from saliva and genotyped. PRSs were constructed based on independent large-scale genome-wide association studies. RESULTS: A total of 156 parents with BD I/II and 180 parents without BD (mean [SD] age, 39.6 [7.9] years; 241 female [72%]) as well as 251 offspring of parents with BD and 158 offspring of parents without BD (mean [SD] age, 10.4 [4.7] years; 213 female [52%]) of European ancestry were analyzed. Participants were assessed a mean of 6.7 times during a mean (SD) of 13 (3.4) years of follow-up (84% retention). More offspring of parents with BD developed BD (58 [23.1%] vs 8 [5.1%]; P < .001) and depression (126 [50.2%] vs 52 [32.9%]; P < .001) compared with offspring of parents without BD. BD PRS was higher in both parents and offspring with BD than parents and offspring without BD (parents: odds ratio, 1.50; 95% CI, 1.19-1.89; P < .001; explained 4.8% of the phenotypic variance vs offspring: hazard ratio, 1.34; 95% CI, 1.03-1.7; P = .02; explained 5.0% of the phenotypic variance). BD PRS did not differ across BD subtypes. In a model combining parental and offspring BD PRS, the parental BD PRS association with offspring BD was fully mediated by offspring BD PRS (hazard ratio, 1.40; 95% CI, 1.05-1.86; P = .02). Parental BD had a stronger direct association than parental or offspring BD PRS with offspring BD risk (hazard ratio, 5.21; 95% CI, 1.86-14.62; P = .002), explaining 30% of the variance. Parental and offspring BD PRS explained 6% of the BD onset variance beyond parental diagnosis. There were no significant between-group differences in PRSs for major depressive disorder, schizophrenia, and attention-deficit/hyperactivity disorder in parents or offspring and they were not significantly associated with BD onset. CONCLUSIONS AND RELEVANCE: The findings of this study add to the extant clinical validation of BD in youth. Parental BD and offspring BD PRS independently associated with the risk of BD in offspring. Although this is promising, the association of BD PRS was relatively small and cannot be used alone to determine BD risk until further developments occur.
引用
- Birmaher B, Hafeman D, Merranko J, et al. Role of Polygenic Risk Score in the Familial Transmission of Bipolar Disorder in Youth. JAMA Psychiatry. 2022. PMID: 34935868. doi:10.1001/jamapsychiatry.2021.3700
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。